Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort
{{output}}
Background: Molecular profiling and subsequent discussions in the Molecular Tumor Board (MTB) within the network of Centers for Personalized Medicine (CPM) have expanded therapeutic options for neuro-oncology patients. Here, we p... ...
